Nihar Bhakta

Lesinurad Combined With Allopurinol: A Randomized, Double‐Blind, Placebo‐Controlled Study in Gout Patients With an Inadequate Response to Standard‐of‐Care Allopurinol (a US‐Based Study)

Kenneth G. Saag, David Fitzpatrick, Jeff Kopicko et al. · Arthritis & Rheumatology · 2016 · 180 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)

Thomas Bardin, Robert T. Keenan, Puja Khanna et al. · Annals of the Rheumatic Diseases · 2016 · 166 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmacotherapy +16

Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial

Nicola Dalbeth, Graeme Jones, Robert Terkeltaub et al. · Arthritis & Rheumatology · 2017 · 151 citations · Full text

Pharmacy, Pharmacotherapy, Drug Repurposing +13

Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study

Anne‐Kathrin Tausche, Rieke Alten, Nicola Dalbeth et al. · Lara D. Veeken · 2017 · 118 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study

Deepak L. Bhatt, Guillaume Paré, John W. Eikelboom et al. · European Heart Journal · 2012 · 97 citations · Full text

Medicine, Genetics, Pharmacology +17